How Much TMG Should I Take for High Blood Pressure?

No clinical trial has established a specific dose of trimethylglycine (TMG, also called betaine) that reliably lowers blood pressure in humans. The interest in TMG for blood pressure stems from its ability to reduce homocysteine, an amino acid linked to vascular stiffness and cardiovascular risk. Doses between 1.5 and 6 grams per day have been shown to lower homocysteine in healthy adults, but the leap from “lowers homocysteine” to “lowers blood pressure” involves assumptions that human studies have not yet confirmed. Before reaching for TMG as a blood pressure supplement, the indirect nature of the evidence and a real trade-off involving cholesterol deserve a careful look.

Why TMG Gets Connected to Blood Pressure

TMG is a methyl donor, meaning it hands off a chemical group that the body uses to convert homocysteine into the amino acid methionine. High homocysteine levels have been associated with stiffer arteries, endothelial damage, and elevated blood pressure. A cohort study in Nepal found a statistically significant association between homocysteine levels and blood pressure across different ethnic groups, with people carrying certain genetic variants showing the highest homocysteine concentrations and greater cardiovascular risk.¹ The logic goes: if TMG lowers homocysteine, and homocysteine is linked to high blood pressure, then TMG might help bring blood pressure down.

That chain of reasoning is plausible but unproven. Observational studies can show that two things travel together without proving that fixing one fixes the other. Decades of research on homocysteine-lowering with folic acid and B vitamins have produced mixed results on actual cardiovascular outcomes, and TMG’s story is even less complete because it has been studied far less in blood pressure trials specifically. The best that can be said right now is that TMG reliably lowers homocysteine, and high homocysteine is a recognized risk factor for vascular problems including hypertension.

What Doses Actually Lower Homocysteine

The strongest evidence on TMG dosing comes from studies measuring homocysteine, not blood pressure. A well-designed trial in healthy men and women tested three dose levels: 1.5, 3, and 6 grams daily for six weeks. Fasting homocysteine dropped by about 12% at 1.5 grams, 15% at 3 grams, and 20% at 6 grams compared to placebo.² The effect showed up quickly and held steady through the study period. Even the lowest dose, 1.5 grams, produced a meaningful reduction, which is worth noting because that amount is closer to what someone could get from a diet rich in beets, spinach, and wheat germ.

A meta-analysis pooling five placebo-controlled trials found that supplementation with at least 4 grams per day for a minimum of six weeks reduced plasma homocysteine by about 1.23 μmol/L on average.³ That pooled estimate used studies with doses of 4 to 6 grams daily, so people taking less than 4 grams would expect a smaller reduction, and those taking 6 grams would land toward the upper end of the range. The diminishing returns are apparent: tripling the dose from 1.5 to 6 grams does not triple the effect. You get meaningful homocysteine lowering at the low end, with progressively smaller additional gains as the dose climbs.

If your goal is homocysteine reduction as a proxy strategy for cardiovascular health, the practical range based on existing data is somewhere between 1.5 and 6 grams daily. Most supplement products land at 1 to 3 grams per serving. There is no reason from the literature to push beyond 6 grams, and as the next section explains, there are reasons to be cautious about higher doses.

The Cholesterol Trade-Off

This is where the picture gets complicated for anyone considering TMG specifically for heart health. A randomized trial found that 6 grams per day of betaine for six weeks raised LDL cholesterol by 0.36 mmol/L (roughly 14 mg/dL) and worsened the ratio of total cholesterol to HDL cholesterol.⁴ A systematic review and meta-analysis confirmed this trend, finding that supplementation with at least 4 grams daily increased total cholesterol by about 0.34 mmol/L on average, though the effects on LDL, HDL, and triglycerides individually did not reach statistical significance in the pooled analysis.⁵

For someone taking TMG to support cardiovascular health, raising LDL and total cholesterol is counterproductive. It creates a tension: you may be lowering one risk factor (homocysteine) while nudging another (cholesterol) in the wrong direction. The clinical significance of a 0.34 mmol/L cholesterol bump depends on your starting levels and overall risk profile, but it is not trivial. It is roughly the magnitude that might prompt a conversation with your doctor about dietary changes in a standard lipid panel review. This trade-off is one reason cardiologists have not embraced TMG supplementation for vascular health despite its robust effect on homocysteine. If you already have elevated cholesterol, this concern carries extra weight.

The cholesterol effect appears more consistently at doses of 4 grams and above. Whether lower doses in the 1.5 to 3 gram range carry the same lipid penalty is less clear, because fewer studies have examined lipid outcomes at those doses. It is reasonable to suspect the effect would be smaller at lower doses, but it has not been formally ruled out.

The Nitric Oxide Question

Some proponents of TMG for blood pressure point to nitric oxide, the molecule that signals blood vessels to relax and widen. In theory, if TMG boosted nitric oxide production, it could lower blood pressure through a direct vascular mechanism rather than the indirect homocysteine route. An animal study using spontaneously hypertensive rats found that betaine administration increased nitric oxide levels and protected cerebral microvascular endothelial cells through upregulation of the nitric oxide synthase pathway.⁶ That is a genuinely interesting finding in rodent physiology.

The problem is that the human evidence tells a different story. A controlled trial in healthy adults found that acute betaine supplementation did not increase plasma nitrate levels (a marker of nitric oxide production) and did not alter cardiovascular responses during rest or light-to-moderate exercise.⁷ Whatever happens in hypertensive rat models has not translated into measurable nitric oxide changes in human blood. This is a familiar pattern in nutrition research: animal mechanisms often look promising but fail to replicate across species. The nitric oxide pathway remains a hypothesis for TMG’s potential cardiovascular effects, not an established mechanism in people.

Your Genetics May Matter More Than You Think

Not everyone processes homocysteine the same way. A common genetic variant in the MTHFR gene, known as C677T, reduces the body’s ability to recycle homocysteine through the folate-dependent pathway. People who carry two copies of this variant (the homozygous TT genotype) tend to have substantially higher homocysteine levels. In a cohort study, homozygous carriers averaged homocysteine concentrations of about 19.4 μmol/L compared to 17.4 μmol/L in heterozygous carriers, and the association between homocysteine and blood pressure was statistically significant.¹

This matters for TMG supplementation because TMG works through a different remethylation pathway than folate does. If your MTHFR pathway is genetically sluggish, TMG provides an alternative route for clearing homocysteine. In that scenario, TMG supplementation could be more valuable than it would be for someone whose MTHFR pathway functions normally. It also means that the population most likely to have elevated homocysteine-driven blood pressure is the same population most likely to benefit from TMG’s mechanism of action. If you have been told you carry an MTHFR variant and have elevated homocysteine, a conversation about TMG with your doctor has a stronger rationale than it does for the general population.

Combining TMG with Folate and B Vitamins

Because homocysteine can be recycled through two separate pathways, one dependent on folate and the other on TMG, combining the two approaches might seem like a smart strategy. A study in middle-aged men found that simultaneous supplementation with folate and betaine produced a significant reduction in homocysteine, while vitamin B12 and B6 alone did not reach statistical significance during the study period.⁸ The finding suggests that folate and betaine work through complementary pathways and their effects can stack, at least for homocysteine reduction.

In practical terms, if you are already taking a B-complex or a folate supplement and your homocysteine remains stubbornly elevated, adding TMG gives the body a second independent route for clearing it. Conversely, if you start TMG and want to maximize the homocysteine-lowering effect, making sure your folate status is adequate could amplify the result. The caveat remains the same: lowering homocysteine has not been directly proven to lower blood pressure in randomized trials, so stacking supplements for deeper homocysteine reduction is still a bet on a plausible but unconfirmed mechanism.

How Your Body Absorbs and Clears TMG

TMG is absorbed fast. After a single oral dose, blood levels peak in under an hour, with a half-life for the initial distribution phase of about 35 minutes.⁹ The elimination half-life on a single dose is roughly 14 hours, but with repeated daily dosing it extends to about 41 hours, meaning betaine accumulates in the body over time when taken consistently. This accumulation is relevant for two reasons. First, it explains why the homocysteine-lowering effect can build over weeks of supplementation. Second, it means that if you experience side effects, stopping the supplement will not clear it from your system overnight.

Most people tolerate TMG well at the studied doses. The most commonly reported side effects are mild gastrointestinal symptoms and a fishy body odor at higher doses, caused by the metabolite trimethylamine. Splitting the daily dose across two servings, such as morning and evening, rather than taking it all at once can help reduce both the odor and the GI discomfort. Given the pharmacokinetics, twice-daily dosing also provides more stable blood levels than a single large dose.

TMG and Kidney Disease

People with chronic kidney disease (CKD) are a population where homocysteine levels tend to run high and cardiovascular complications are a leading concern. Animal studies have found that betaine supplementation in CKD models reduced kidney damage, restored antioxidant function, and lowered inflammation.¹⁰ Betaine also appears to support gut health by regulating osmolality and microbiota composition, which is relevant because CKD disrupts the gut-kidney axis.

However, these are animal findings, and CKD patients face unique challenges with supplement metabolism because their kidneys process and excrete substances differently. Betaine’s accumulation pattern with repeated dosing could be more pronounced in someone with impaired renal clearance. If you have kidney disease and are considering TMG, self-dosing based on studies in healthy adults is not appropriate. The dose that is safe and effective may be very different from what the general research suggests.

What TMG Cannot Replace

Even if TMG proves to have modest blood pressure effects in future trials, the magnitude is unlikely to rival established interventions. Reducing sodium intake, increasing potassium-rich foods, regular aerobic exercise, maintaining a healthy weight, and moderating alcohol consumption each independently lower blood pressure by clinically meaningful amounts. Prescription medications, when indicated, produce reductions that dietary supplements rarely match. TMG supplementation, even at its most optimistic, would be an adjunct to these strategies rather than a substitute for any of them.

The absence of TMG from major hypertension guidelines is not an oversight. Guideline committees evaluate evidence for direct effects on blood pressure outcomes, and that evidence does not exist for TMG. What exists is evidence that TMG lowers homocysteine, a plausible but unproven intermediary. If you want to try TMG as part of a broader cardiovascular strategy, a dose in the range of 1.5 to 3 grams daily gives you meaningful homocysteine reduction with a lower risk of the cholesterol increase seen at 4 to 6 grams. Monitoring your lipid panel after starting supplementation is a reasonable precaution, especially if your cholesterol is already borderline or elevated.

Dietary Betaine Versus Supplements

Before reaching for capsules or powder, it is worth knowing that TMG is present in ordinary foods. Wheat bran, wheat germ, spinach, beets, quinoa, and shellfish are among the richest dietary sources. A typical Western diet supplies somewhere around 100 to 400 milligrams of betaine per day, well below the 1,500 milligrams that produced a measurable homocysteine reduction in trials. Pushing dietary betaine intake toward supplement-level doses through food alone is difficult but not impossible if you deliberately build meals around high-betaine ingredients. A large bowl of cooked quinoa with roasted beets and spinach could deliver several hundred milligrams in a single sitting.

The advantage of food-based betaine is that it comes packaged with potassium, magnesium, fiber, and nitrates (especially from beets), all of which have their own evidence base for supporting healthy blood pressure. The disadvantage is that you cannot realistically reach 3 to 6 grams per day through diet alone, so if you are specifically targeting homocysteine lowering at the doses shown to be effective in trials, supplementation is the practical route. A middle-ground approach, increasing dietary betaine for general cardiovascular benefit while supplementing modestly if homocysteine levels warrant it, makes sense for people who want to hedge their bets without committing to high-dose supplementation and its cholesterol implications.